 |
|
|
| |
Improved Renal Laboratory Parameters in Chronic HBV (CHB) Patients Treated With Tenofovir Alafenamide (TAF) Compared With Tenofovir Disoproxil Fumarate (TDF)
|
| |
| |
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
N Furusyo1, K Argawal2, K-S Byun3, J-S Hwang4, JF Flaherty5, K Kim5, A Gaggar5, GM Subramanian5, M Jablkowski6, A Yakovlev7, H Trinh8, M Buti9
1Kyushu Medical Center, Fukuoka, Japan; 2Kings College Hospital NHS Trust, London, United Kingdom; 3Internal Medicine, Korea University, Seoul, Korea (the Republic of); 4Keimyung University, Dongsan Medical Center, Daegu, Korea (the Republic of); 5Gilead Sciences, Foster City, CA, United States; 6Infectious and Liver Diseases, Oddziak Obserwacyjno-Zakazny, Lodz, Poland;
7Clinical Infectious Diseases Hospital n.a. S.P.Botkin, St. Petersburg, Russian Federation; 8Silicon Valley Research Institute, San Jose, CA, United States;
9Hospital Universitari Vall dÕHebron, Barcelona, Spain
|
| |
|
|
|
|
|
